Which patients are candidates for dipeptidyl peptidase IV inhibitors?

Am J Health Syst Pharm. 2007 Jun;64(12):1261. doi: 10.2146/ajhp070104.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adamantane / analogs & derivatives
  • Adamantane / pharmacology
  • Adamantane / therapeutic use
  • Ambulatory Care* / trends
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / enzymology
  • Dipeptidyl Peptidase 4 / blood
  • Dipeptidyl-Peptidase IV Inhibitors*
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Humans
  • Nitriles / pharmacology
  • Nitriles / therapeutic use
  • Pyrrolidines / pharmacology
  • Pyrrolidines / therapeutic use
  • Vildagliptin

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Enzyme Inhibitors
  • Nitriles
  • Pyrrolidines
  • Dipeptidyl Peptidase 4
  • Vildagliptin
  • Adamantane